Skip to main content
Equibles

UBS Group AG

Position in WHWK — Whitehawk Therapeutics, Inc.

CIK 1610520 ZURICH, V8
Back to WHWK Full portfolio

Position in WHWK

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$232,851
+$193,391 QoQ
Shares Held
50,841
+344.5% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 78 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in WHWK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. WHWK ranks #332 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in WHWK

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $232,851 50,841
2026-03-31 $39,460 11,438
2025-12-31 $72,222 29,844
2025-09-30 $10,816 5,693
2025-06-30 $16,218 8,673
2025-03-31 $63,308 35,567
2024-12-31 $186,693 59,174
2024-09-30 $104,455 50,707
2024-06-30 $102,732 70,365
2024-03-31 $48,463 20,711
2023-12-31 $35,875 17,760
2023-09-30 $44,169 9,126
2023-06-30 $63,372 9,265
2023-03-31 $46,509 6,424
2022-12-31 $64,470 5,025
2022-06-30 $202,465 16,434
2022-03-31 $961,926 56,684
2021-12-31 $581,868 24,094
2021-09-30 $7,047 240